Manufacturers Life Insurance Company, The Recursion Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 124,654 shares of RXRX stock, worth $927,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,654
Previous 111,613
11.68%
Holding current value
$927,425
Previous $837,000
1.91%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RXRX
# of Institutions
287Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$244 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$188 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$129 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$114 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.34B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...